Skip to main content

Research

Leading Roles for Cardiff University Professors in REF 2029

3 June 2025

Professor Rick Delbridge and Professor Chris Taylor have been appointed Chair and Deputy Chair on two Research Excellence Framework (REF 2029) Sub-Panels.

New funding award boosts Ireland-Wales research collaboration

2 June 2025

Cardiff University has been awarded funding for four innovative research collaborations with University College Dublin through the newly launched Research Alliance Award.

Sleep problems could double risk of dementia in later life

29 May 2025

Sleep disorders could increase the risk of developing dementia and other neurodegenerative conditions later in life.

At-home blood cancer treatment trial

28 May 2025

Clinical trial aims to provide a new treatment for a rare blood cancer that can be taken at home.

New guidelines for identifying increased risk of psychological and heart conditions in rare skin condition

28 May 2025

Research by Cardiff University has led to changes in international guidelines for the screening of a rare skin condition.

New Learned Society of Wales Fellows to help solve the challenges the world faces

28 May 2025

15 Cardiff University academics have joined the elite ranks of the of the Learned Society of Wales.

Amazon could survive long-term drought but at a high cost, study finds

22 May 2025

Rainforest could lose many of its largest trees, releasing carbon into the air and reducing its carbon sink capabilities

Cardiff scientist elected to lead global gravitational-wave collaboration

19 May 2025

Professor Stephen Fairhurst becomes first LIGO Scientific Collaboration Spokesperson from UK institution

Policies targeting road transport emissions could save 1.9 million lives globally by 2040, new study finds

19 May 2025

Analysis demonstrates dramatic health benefits from combining emission standards, electric vehicles, accelerated fleet renewal, and clean electricity for electric vehicles

New trial for gene therapy for frontotemporal dementia

15 May 2025

The ASPIRE-FTD clinical trial will investigate the use of a gene therapy in people with frontotemporal dementia.